nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—AMN—renal system—muscle cancer	0.0185	0.0483	CbGeAlD
Hydroxocobalamin—CUBN—renal system—muscle cancer	0.0156	0.0407	CbGeAlD
Hydroxocobalamin—MMACHC—head—muscle cancer	0.015	0.0392	CbGeAlD
Hydroxocobalamin—CASP9—renal system—muscle cancer	0.0129	0.0337	CbGeAlD
Hydroxocobalamin—TCN2—renal system—muscle cancer	0.0126	0.0329	CbGeAlD
Hydroxocobalamin—AMN—testis—muscle cancer	0.012	0.0312	CbGeAlD
Hydroxocobalamin—MMAA—vagina—muscle cancer	0.0107	0.0278	CbGeAlD
Hydroxocobalamin—TCN1—bone marrow—muscle cancer	0.0106	0.0277	CbGeAlD
Hydroxocobalamin—TCN1—vagina—muscle cancer	0.0102	0.0265	CbGeAlD
Hydroxocobalamin—CUBN—testis—muscle cancer	0.0101	0.0263	CbGeAlD
Hydroxocobalamin—MMAB—vagina—muscle cancer	0.01	0.0261	CbGeAlD
Hydroxocobalamin—MUT—renal system—muscle cancer	0.00991	0.0259	CbGeAlD
Hydroxocobalamin—MMAA—head—muscle cancer	0.00986	0.0257	CbGeAlD
Hydroxocobalamin—TCN2—tendon—muscle cancer	0.00984	0.0257	CbGeAlD
Hydroxocobalamin—MMAA—testis—muscle cancer	0.00952	0.0248	CbGeAlD
Hydroxocobalamin—TCN1—head—muscle cancer	0.00939	0.0245	CbGeAlD
Hydroxocobalamin—CASP9—vagina—muscle cancer	0.00935	0.0244	CbGeAlD
Hydroxocobalamin—MMAB—head—muscle cancer	0.00925	0.0241	CbGeAlD
Hydroxocobalamin—MMAB—testis—muscle cancer	0.00893	0.0233	CbGeAlD
Hydroxocobalamin—MTRR—renal system—muscle cancer	0.0089	0.0232	CbGeAlD
Hydroxocobalamin—MUT—cardiac atrium—muscle cancer	0.00887	0.0232	CbGeAlD
Hydroxocobalamin—CASP9—head—muscle cancer	0.00864	0.0225	CbGeAlD
Hydroxocobalamin—TCN2—head—muscle cancer	0.00843	0.022	CbGeAlD
Hydroxocobalamin—CASP9—testis—muscle cancer	0.00834	0.0218	CbGeAlD
Hydroxocobalamin—TCN2—testis—muscle cancer	0.00814	0.0212	CbGeAlD
Hydroxocobalamin—MTRR—cardiac atrium—muscle cancer	0.00797	0.0208	CbGeAlD
Hydroxocobalamin—MTR—renal system—muscle cancer	0.00777	0.0203	CbGeAlD
Hydroxocobalamin—MUT—tendon—muscle cancer	0.00773	0.0202	CbGeAlD
Hydroxocobalamin—MUT—bone marrow—muscle cancer	0.00749	0.0195	CbGeAlD
Hydroxocobalamin—Folliculitis—Dactinomycin—muscle cancer	0.00721	0.0286	CcSEcCtD
Hydroxocobalamin—MUT—vagina—muscle cancer	0.00718	0.0187	CbGeAlD
Hydroxocobalamin—MTR—cardiac atrium—muscle cancer	0.00696	0.0181	CbGeAlD
Hydroxocobalamin—MTRR—tendon—muscle cancer	0.00695	0.0181	CbGeAlD
Hydroxocobalamin—MTRR—bone marrow—muscle cancer	0.00673	0.0176	CbGeAlD
Hydroxocobalamin—Throat tightness—Etoposide—muscle cancer	0.00669	0.0265	CcSEcCtD
Hydroxocobalamin—MUT—head—muscle cancer	0.00663	0.0173	CbGeAlD
Hydroxocobalamin—MTRR—vagina—muscle cancer	0.00645	0.0168	CbGeAlD
Hydroxocobalamin—MUT—testis—muscle cancer	0.0064	0.0167	CbGeAlD
Hydroxocobalamin—MTR—tendon—muscle cancer	0.00606	0.0158	CbGeAlD
Hydroxocobalamin—MTRR—head—muscle cancer	0.00596	0.0155	CbGeAlD
Hydroxocobalamin—MTR—bone marrow—muscle cancer	0.00587	0.0153	CbGeAlD
Hydroxocobalamin—MTRR—testis—muscle cancer	0.00576	0.015	CbGeAlD
Hydroxocobalamin—MTR—vagina—muscle cancer	0.00563	0.0147	CbGeAlD
Hydroxocobalamin—MTR—head—muscle cancer	0.0052	0.0136	CbGeAlD
Hydroxocobalamin—Extravasation—Dactinomycin—muscle cancer	0.00519	0.0206	CcSEcCtD
Hydroxocobalamin—MTR—testis—muscle cancer	0.00502	0.0131	CbGeAlD
Hydroxocobalamin—Sensitisation—Doxorubicin—muscle cancer	0.00476	0.0189	CcSEcCtD
Hydroxocobalamin—Extravasation—Vincristine—muscle cancer	0.00464	0.0184	CcSEcCtD
Hydroxocobalamin—Bullous eruption—Doxorubicin—muscle cancer	0.0043	0.0171	CcSEcCtD
Hydroxocobalamin—Haematochezia—Doxorubicin—muscle cancer	0.00422	0.0167	CcSEcCtD
Hydroxocobalamin—Phlebitis—Dactinomycin—muscle cancer	0.00382	0.0151	CcSEcCtD
Hydroxocobalamin—Extravasation—Etoposide—muscle cancer	0.00376	0.0149	CcSEcCtD
Hydroxocobalamin—Chest discomfort—Etoposide—muscle cancer	0.00371	0.0147	CcSEcCtD
Hydroxocobalamin—Venous thrombosis—Doxorubicin—muscle cancer	0.00315	0.0125	CcSEcCtD
Hydroxocobalamin—Folliculitis—Methotrexate—muscle cancer	0.00312	0.0124	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Vincristine—muscle cancer	0.00295	0.0117	CcSEcCtD
Hydroxocobalamin—Dysphagia—Dactinomycin—muscle cancer	0.00284	0.0113	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Vincristine—muscle cancer	0.00279	0.0111	CcSEcCtD
Hydroxocobalamin—Lung disorder—Methotrexate—muscle cancer	0.00277	0.011	CcSEcCtD
Hydroxocobalamin—Phlebitis—Etoposide—muscle cancer	0.00276	0.011	CcSEcCtD
Hydroxocobalamin—Folliculitis—Doxorubicin—muscle cancer	0.00271	0.0107	CcSEcCtD
Hydroxocobalamin—Swelling—Etoposide—muscle cancer	0.0027	0.0107	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Etoposide—muscle cancer	0.00262	0.0104	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Methotrexate—muscle cancer	0.00256	0.0102	CcSEcCtD
Hydroxocobalamin—Redness—Doxorubicin—muscle cancer	0.00252	0.00999	CcSEcCtD
Hydroxocobalamin—Thrombosis—Doxorubicin—muscle cancer	0.0024	0.00952	CcSEcCtD
Hydroxocobalamin—Lung disorder—Doxorubicin—muscle cancer	0.0024	0.00952	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Etoposide—muscle cancer	0.00226	0.00897	CcSEcCtD
Hydroxocobalamin—Extravasation—Methotrexate—muscle cancer	0.00225	0.00892	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Doxorubicin—muscle cancer	0.00222	0.0088	CcSEcCtD
Hydroxocobalamin—Feeling hot—Doxorubicin—muscle cancer	0.00217	0.00859	CcSEcCtD
Hydroxocobalamin—Dysphagia—Etoposide—muscle cancer	0.00206	0.00815	CcSEcCtD
Hydroxocobalamin—Chills—Dactinomycin—muscle cancer	0.00204	0.00809	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Vincristine—muscle cancer	0.00201	0.00796	CcSEcCtD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—FOXO1—muscle cancer	0.00201	0.0055	CbGpPWpGaD
Hydroxocobalamin—Urethral disorder—Vincristine—muscle cancer	0.00199	0.0079	CcSEcCtD
Hydroxocobalamin—Erythema—Dactinomycin—muscle cancer	0.00198	0.00785	CcSEcCtD
Hydroxocobalamin—Extravasation—Doxorubicin—muscle cancer	0.00195	0.00773	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—FOXO4—muscle cancer	0.00193	0.00529	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—FOXO4—muscle cancer	0.00192	0.00527	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—FOXO4—muscle cancer	0.00191	0.00524	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—FOXO4—muscle cancer	0.0019	0.00522	CbGpPWpGaD
Hydroxocobalamin—Cardiac disorder—Vincristine—muscle cancer	0.00189	0.00748	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—FH—muscle cancer	0.00188	0.00517	CbGpPWpGaD
Hydroxocobalamin—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00188	0.00746	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.00188	0.00515	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—FOXO4—muscle cancer	0.00187	0.00514	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Vincristine—muscle cancer	0.00184	0.00731	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Dactinomycin—muscle cancer	0.00184	0.00728	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Vincristine—muscle cancer	0.00183	0.00726	CcSEcCtD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—KIT—muscle cancer	0.00179	0.00492	CbGpPWpGaD
Hydroxocobalamin—MTR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	0.00179	0.00491	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—FOXO4—muscle cancer	0.00179	0.00491	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.00179	0.00491	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—FOXO4—muscle cancer	0.00179	0.00491	CbGpPWpGaD
Hydroxocobalamin—Malaise—Dactinomycin—muscle cancer	0.00179	0.00708	CcSEcCtD
Hydroxocobalamin—Mental disorder—Vincristine—muscle cancer	0.00178	0.00706	CcSEcCtD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—PTGS2—muscle cancer	0.00178	0.00487	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—FOXO4—muscle cancer	0.00177	0.00486	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—FOXO4—muscle cancer	0.00176	0.00482	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—FOXO4—muscle cancer	0.00175	0.0048	CbGpPWpGaD
Hydroxocobalamin—Pulmonary oedema—Methotrexate—muscle cancer	0.00175	0.00693	CcSEcCtD
Hydroxocobalamin—CASP9—DNA Damage Response—MDM2—muscle cancer	0.0017	0.00467	CbGpPWpGaD
Hydroxocobalamin—Injection site reaction—Doxorubicin—muscle cancer	0.00169	0.0067	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.00168	0.00462	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—FH—muscle cancer	0.00168	0.00461	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—FH—muscle cancer	0.00168	0.00461	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Dactinomycin—muscle cancer	0.00167	0.0066	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—FOXO4—muscle cancer	0.00165	0.00454	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—MDM2—muscle cancer	0.00165	0.00452	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—TP53—muscle cancer	0.00163	0.00448	CbGpPWpGaD
Hydroxocobalamin—Urinary tract disorder—Etoposide—muscle cancer	0.00163	0.00645	CcSEcCtD
Hydroxocobalamin—Agitation—Vincristine—muscle cancer	0.00163	0.00645	CcSEcCtD
Hydroxocobalamin—Oedema—Dactinomycin—muscle cancer	0.00162	0.00641	CcSEcCtD
Hydroxocobalamin—CASP9—PI-3K cascade—KIT—muscle cancer	0.00161	0.00443	CbGpPWpGaD
Hydroxocobalamin—Urethral disorder—Etoposide—muscle cancer	0.00161	0.0064	CcSEcCtD
Hydroxocobalamin—Infection—Dactinomycin—muscle cancer	0.00161	0.00637	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—FH—muscle cancer	0.0016	0.0044	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—FOXO1—muscle cancer	0.00158	0.00435	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—FOXO4—muscle cancer	0.00158	0.00435	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—KIT—muscle cancer	0.00158	0.00433	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—KIT—muscle cancer	0.00156	0.00429	CbGpPWpGaD
Hydroxocobalamin—CASP9—Intrinsic Pathway for Apoptosis—TP53—muscle cancer	0.00156	0.00427	CbGpPWpGaD
Hydroxocobalamin—CASP9—Amyotrophic lateral sclerosis (ALS)—TP53—muscle cancer	0.00156	0.00427	CbGpPWpGaD
Hydroxocobalamin—Eye disorder—Etoposide—muscle cancer	0.00154	0.0061	CcSEcCtD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—muscle cancer	0.00153	0.00419	CbGpPWpGaD
Hydroxocobalamin—Cardiac disorder—Etoposide—muscle cancer	0.00153	0.00606	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—FOXO1—muscle cancer	0.00152	0.00416	CbGpPWpGaD
Hydroxocobalamin—Pulmonary oedema—Doxorubicin—muscle cancer	0.00151	0.006	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.0015	0.00411	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Etoposide—muscle cancer	0.00149	0.00592	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by ERBB4—FOXO1—muscle cancer	0.00149	0.00409	CbGpPWpGaD
Hydroxocobalamin—Immune system disorder—Etoposide—muscle cancer	0.00149	0.0059	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Etoposide—muscle cancer	0.00148	0.00588	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—CDKN2A—muscle cancer	0.00148	0.00407	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—FH—muscle cancer	0.00148	0.00406	CbGpPWpGaD
Hydroxocobalamin—Chills—Etoposide—muscle cancer	0.00148	0.00586	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Vincristine—muscle cancer	0.00144	0.00572	CcSEcCtD
Hydroxocobalamin—Oedema—Vincristine—muscle cancer	0.00144	0.00572	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—MDM2—muscle cancer	0.00144	0.00395	CbGpPWpGaD
Hydroxocobalamin—Infection—Vincristine—muscle cancer	0.00143	0.00569	CcSEcCtD
Hydroxocobalamin—Phlebitis—Doxorubicin—muscle cancer	0.00143	0.00568	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—FOXO1—muscle cancer	0.00142	0.00391	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—FOXO1—muscle cancer	0.00142	0.00389	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Vincristine—muscle cancer	0.00142	0.00561	CcSEcCtD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—MDM2—muscle cancer	0.00141	0.00387	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—FOXO1—muscle cancer	0.00141	0.00387	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—FOXO1—muscle cancer	0.0014	0.00385	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—CDKN2A—muscle cancer	0.00139	0.00382	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Cancer Pathway—TP53—muscle cancer	0.00138	0.0038	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—FOXO1—muscle cancer	0.00138	0.0038	CbGpPWpGaD
Hydroxocobalamin—Pain—Dactinomycin—muscle cancer	0.00138	0.00548	CcSEcCtD
Hydroxocobalamin—Eczema—Doxorubicin—muscle cancer	0.00137	0.00545	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—ENO2—muscle cancer	0.00136	0.00374	CbGpPWpGaD
Hydroxocobalamin—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00136	0.0054	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Dactinomycin—muscle cancer	0.00133	0.00528	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Etoposide—muscle cancer	0.00133	0.00527	CcSEcCtD
Hydroxocobalamin—MTR—Folate Metabolism—TP53—muscle cancer	0.00133	0.00365	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—FOXO1—muscle cancer	0.00132	0.00362	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—FOXO1—muscle cancer	0.00132	0.00362	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.00132	0.00362	CbGpPWpGaD
Hydroxocobalamin—Hot flush—Doxorubicin—muscle cancer	0.00132	0.00523	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—FOXO1—muscle cancer	0.00131	0.00359	CbGpPWpGaD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—muscle cancer	0.00131	0.00519	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—FOXO1—muscle cancer	0.0013	0.00356	CbGpPWpGaD
Hydroxocobalamin—Malaise—Etoposide—muscle cancer	0.00129	0.00512	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—muscle cancer	0.00129	0.00512	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by PDGF—FOXO1—muscle cancer	0.00129	0.00354	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Dactinomycin—muscle cancer	0.00128	0.00507	CcSEcCtD
Hydroxocobalamin—CASP9—PI-3K cascade—MDM2—muscle cancer	0.00127	0.00349	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—MED12—muscle cancer	0.00125	0.00344	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Vincristine—muscle cancer	0.00125	0.00494	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—ENO2—muscle cancer	0.00125	0.00342	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—ENO2—muscle cancer	0.00125	0.00342	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—MDM2—muscle cancer	0.00124	0.00341	CbGpPWpGaD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—muscle cancer	0.00124	0.00491	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—HMGA1—muscle cancer	0.00124	0.0034	CbGpPWpGaD
Hydroxocobalamin—Pain—Vincristine—muscle cancer	0.00123	0.0049	CcSEcCtD
Hydroxocobalamin—CASP9—GAB1 signalosome—MDM2—muscle cancer	0.00123	0.00338	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—FOXO1—muscle cancer	0.00122	0.00335	CbGpPWpGaD
Hydroxocobalamin—Chest pain—Etoposide—muscle cancer	0.00122	0.00484	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—FOXO4—muscle cancer	0.00122	0.00334	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—FH—muscle cancer	0.00121	0.00333	CbGpPWpGaD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00121	0.0048	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—KIT—muscle cancer	0.00121	0.00331	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Etoposide—muscle cancer	0.00121	0.00478	CcSEcCtD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—MDM2—muscle cancer	0.0012	0.0033	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Dactinomycin—muscle cancer	0.00119	0.00472	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—muscle cancer	0.00118	0.00468	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—muscle cancer	0.00117	0.00465	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Etoposide—muscle cancer	0.00117	0.00464	CcSEcCtD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—FOXO1—muscle cancer	0.00117	0.00321	CbGpPWpGaD
Hydroxocobalamin—Infection—Etoposide—muscle cancer	0.00116	0.00461	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—ENO2—muscle cancer	0.00116	0.00318	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—KIT—muscle cancer	0.00115	0.00317	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—VEGFA—muscle cancer	0.00115	0.00315	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—MED12—muscle cancer	0.00115	0.00314	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—MED12—muscle cancer	0.00115	0.00314	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Etoposide—muscle cancer	0.00114	0.00453	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vincristine—muscle cancer	0.00114	0.00453	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—ENO2—muscle cancer	0.00114	0.00313	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—KIT—muscle cancer	0.00114	0.00312	CbGpPWpGaD
Hydroxocobalamin—Skin disorder—Etoposide—muscle cancer	0.00114	0.0045	CcSEcCtD
Hydroxocobalamin—MMAB—Disease—HMGA1—muscle cancer	0.00113	0.00311	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—HMGA1—muscle cancer	0.00113	0.00311	CbGpPWpGaD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—muscle cancer	0.00112	0.00445	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—FOXO4—muscle cancer	0.00111	0.00305	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Dactinomycin—muscle cancer	0.00111	0.00438	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—KIT—muscle cancer	0.00109	0.00298	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—KIT—muscle cancer	0.00108	0.00296	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—KIT—muscle cancer	0.00107	0.00295	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—KIT—muscle cancer	0.00107	0.00293	CbGpPWpGaD
Hydroxocobalamin—Dysphagia—Doxorubicin—muscle cancer	0.00107	0.00423	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—MED12—muscle cancer	0.00106	0.00292	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Vincristine—muscle cancer	0.00106	0.00422	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—KIT—muscle cancer	0.00105	0.00289	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—HMGA1—muscle cancer	0.00105	0.00289	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—ENO2—muscle cancer	0.00104	0.00286	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—ENO2—muscle cancer	0.00104	0.00286	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Etoposide—muscle cancer	0.00104	0.00413	CcSEcCtD
Hydroxocobalamin—MMAA—Disease—ENO2—muscle cancer	0.00103	0.00283	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—ENO2—muscle cancer	0.00103	0.00283	CbGpPWpGaD
Hydroxocobalamin—Rash—Dactinomycin—muscle cancer	0.00102	0.00404	CcSEcCtD
Hydroxocobalamin—MMAB—Disease—FOXO4—muscle cancer	0.00102	0.00279	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—FOXO4—muscle cancer	0.00102	0.00279	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Etoposide—muscle cancer	0.00101	0.004	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—KIT—muscle cancer	0.00101	0.00276	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.00101	0.00276	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—KIT—muscle cancer	0.00101	0.00276	CbGpPWpGaD
Hydroxocobalamin—Pain—Etoposide—muscle cancer	0.001	0.00397	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by EGFR—KIT—muscle cancer	0.000997	0.00274	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—FH—muscle cancer	0.00099	0.00272	CbGpPWpGaD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	0.000989	0.00271	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—KIT—muscle cancer	0.000989	0.00271	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Vincristine—muscle cancer	0.000988	0.00392	CcSEcCtD
Hydroxocobalamin—MUT—Disease—ENO2—muscle cancer	0.000985	0.0027	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—KIT—muscle cancer	0.000984	0.0027	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD34—muscle cancer	0.000982	0.00269	CbGpPWpGaD
Hydroxocobalamin—CASP9—DNA Damage Response—TP53—muscle cancer	0.000978	0.00268	CbGpPWpGaD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—muscle cancer	0.000974	0.00386	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—ENO2—muscle cancer	0.000971	0.00266	CbGpPWpGaD
Hydroxocobalamin—Urethral disorder—Methotrexate—muscle cancer	0.000967	0.00383	CcSEcCtD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—TP53—muscle cancer	0.000966	0.00265	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Etoposide—muscle cancer	0.000964	0.00382	CcSEcCtD
Hydroxocobalamin—Nausea—Dactinomycin—muscle cancer	0.00096	0.00381	CcSEcCtD
Hydroxocobalamin—Dizziness—Vincristine—muscle cancer	0.000955	0.00379	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—MDM2—muscle cancer	0.000951	0.00261	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—MED12—muscle cancer	0.000949	0.0026	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—MED12—muscle cancer	0.000949	0.0026	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—FOXO4—muscle cancer	0.000945	0.00259	CbGpPWpGaD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—TP53—muscle cancer	0.000944	0.00259	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—HMGA1—muscle cancer	0.000939	0.00258	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—HMGA1—muscle cancer	0.000939	0.00258	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—KIT—muscle cancer	0.000931	0.00256	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Etoposide—muscle cancer	0.000929	0.00368	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Etoposide—muscle cancer	0.000925	0.00367	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—muscle cancer	0.000922	0.00365	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—muscle cancer	0.000915	0.00363	CcSEcCtD
Hydroxocobalamin—Rash—Vincristine—muscle cancer	0.000911	0.00361	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vincristine—muscle cancer	0.00091	0.00361	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—MDM2—muscle cancer	0.00091	0.0025	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—ENO2—muscle cancer	0.000909	0.0025	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—MED12—muscle cancer	0.000905	0.00248	CbGpPWpGaD
Hydroxocobalamin—Headache—Vincristine—muscle cancer	0.000905	0.00359	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.0009	0.00247	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—FOXO1—muscle cancer	0.0009	0.00247	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—HMGA1—muscle cancer	0.000896	0.00246	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—MDM2—muscle cancer	0.000895	0.00246	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Methotrexate—muscle cancer	0.000895	0.00355	CcSEcCtD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	0.000891	0.00245	CbGpPWpGaD
Hydroxocobalamin—Immune system disorder—Methotrexate—muscle cancer	0.000891	0.00353	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—muscle cancer	0.000889	0.00352	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—muscle cancer	0.000885	0.00351	CcSEcCtD
Hydroxocobalamin—CASP9—Alzheimers Disease—TP53—muscle cancer	0.000867	0.00238	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—ENO2—muscle cancer	0.000865	0.00237	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ENO2—muscle cancer	0.000865	0.00237	CbGpPWpGaD
Hydroxocobalamin—Mental disorder—Methotrexate—muscle cancer	0.000864	0.00343	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—muscle cancer	0.000862	0.00342	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—muscle cancer	0.000859	0.0034	CcSEcCtD
Hydroxocobalamin—Nausea—Vincristine—muscle cancer	0.000858	0.0034	CcSEcCtD
Hydroxocobalamin—CASP9—Downstream signal transduction—MDM2—muscle cancer	0.000855	0.00235	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—MDM2—muscle cancer	0.000851	0.00233	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—MDM2—muscle cancer	0.000847	0.00232	CbGpPWpGaD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—muscle cancer	0.000843	0.00334	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 signaling—MDM2—muscle cancer	0.000842	0.00231	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—FOXO4—muscle cancer	0.000842	0.00231	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—FOXO4—muscle cancer	0.000842	0.00231	CbGpPWpGaD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—muscle cancer	0.000841	0.00334	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—muscle cancer	0.000837	0.00332	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—MED12—muscle cancer	0.000835	0.00229	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—MDM2—muscle cancer	0.00083	0.00228	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Etoposide—muscle cancer	0.000828	0.00328	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—HMGA1—muscle cancer	0.000827	0.00227	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—muscle cancer	0.000826	0.00227	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ENO2—muscle cancer	0.000825	0.00226	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—FOXO1—muscle cancer	0.000821	0.00225	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—FOXO4—muscle cancer	0.000803	0.0022	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Etoposide—muscle cancer	0.0008	0.00317	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—muscle cancer	0.000798	0.00316	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—muscle cancer	0.000797	0.00316	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—muscle cancer	0.000793	0.00314	CcSEcCtD
Hydroxocobalamin—CASP9—DAP12 interactions—MDM2—muscle cancer	0.000793	0.00217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000793	0.00217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—MDM2—muscle cancer	0.000793	0.00217	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—MDM2—muscle cancer	0.000785	0.00216	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000779	0.00214	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—MDM2—muscle cancer	0.000775	0.00213	CbGpPWpGaD
Hydroxocobalamin—Angiopathy—Doxorubicin—muscle cancer	0.000775	0.00307	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—TP53—muscle cancer	0.000774	0.00212	CbGpPWpGaD
Hydroxocobalamin—Malaise—Methotrexate—muscle cancer	0.000774	0.00307	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—muscle cancer	0.000774	0.00307	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling Pathways—KIDINS220—muscle cancer	0.000773	0.00212	CbGpPWpGaD
Hydroxocobalamin—Immune system disorder—Doxorubicin—muscle cancer	0.000771	0.00306	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—muscle cancer	0.00077	0.00305	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—muscle cancer	0.000766	0.00304	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—muscle cancer	0.000763	0.00302	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—ENO2—muscle cancer	0.000762	0.00209	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—FOXO1—muscle cancer	0.000751	0.00206	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—FOXO1—muscle cancer	0.000751	0.00206	CbGpPWpGaD
Hydroxocobalamin—Mental disorder—Doxorubicin—muscle cancer	0.000748	0.00297	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—ENO2—muscle cancer	0.000747	0.00205	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000746	0.00205	CbGpPWpGaD
Hydroxocobalamin—Erythema—Doxorubicin—muscle cancer	0.000743	0.00295	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—FOXO4—muscle cancer	0.000741	0.00203	CbGpPWpGaD
Hydroxocobalamin—Rash—Etoposide—muscle cancer	0.000738	0.00292	CcSEcCtD
Hydroxocobalamin—Dermatitis—Etoposide—muscle cancer	0.000737	0.00292	CcSEcCtD
Hydroxocobalamin—CASP9—B Cell Activation—MDM2—muscle cancer	0.000733	0.00201	CbGpPWpGaD
Hydroxocobalamin—Headache—Etoposide—muscle cancer	0.000733	0.00291	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—muscle cancer	0.000731	0.0029	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000726	0.00288	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—muscle cancer	0.000722	0.00286	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000719	0.00197	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000702	0.00193	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—muscle cancer	0.000701	0.00278	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—FOXO1—muscle cancer	0.000698	0.00191	CbGpPWpGaD
Hydroxocobalamin—Infection—Methotrexate—muscle cancer	0.000696	0.00276	CcSEcCtD
Hydroxocobalamin—Nausea—Etoposide—muscle cancer	0.000695	0.00275	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—FOXO4—muscle cancer	0.000695	0.00191	CbGpPWpGaD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—muscle cancer	0.00069	0.00273	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—muscle cancer	0.000687	0.00272	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—MED12—muscle cancer	0.000686	0.00188	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—KIT—muscle cancer	0.000686	0.00188	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.000683	0.00188	CbGpPWpGaD
Hydroxocobalamin—Agitation—Doxorubicin—muscle cancer	0.000683	0.00271	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—muscle cancer	0.000681	0.0027	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—HMGA1—muscle cancer	0.000679	0.00186	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000677	0.00186	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000677	0.00186	CbGpPWpGaD
Hydroxocobalamin—Malaise—Doxorubicin—muscle cancer	0.00067	0.00266	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—FOXO4—muscle cancer	0.000667	0.00183	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000645	0.00177	CbGpPWpGaD
Hydroxocobalamin—Chest pain—Doxorubicin—muscle cancer	0.000633	0.00251	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000629	0.00249	CcSEcCtD
Hydroxocobalamin—MTRR—Metabolism—ENO2—muscle cancer	0.000625	0.00172	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Doxorubicin—muscle cancer	0.000625	0.00248	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—KIT—muscle cancer	0.000625	0.00172	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Methotrexate—muscle cancer	0.000625	0.00248	CcSEcCtD
Hydroxocobalamin—MMAA—Disease—FOXO1—muscle cancer	0.000622	0.00171	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—FOXO1—muscle cancer	0.000622	0.00171	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Methotrexate—muscle cancer	0.000617	0.00245	CcSEcCtD
Hydroxocobalamin—MTR—Disease—ENO2—muscle cancer	0.000609	0.00167	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FOXO4—muscle cancer	0.000609	0.00167	CbGpPWpGaD
Hydroxocobalamin—Oedema—Doxorubicin—muscle cancer	0.000607	0.00241	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000607	0.00241	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000605	0.0024	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—muscle cancer	0.000603	0.00239	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—muscle cancer	0.000599	0.00238	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	0.000596	0.00163	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD34—muscle cancer	0.000595	0.00163	CbGpPWpGaD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—muscle cancer	0.000595	0.00236	CcSEcCtD
Hydroxocobalamin—MUT—Disease—FOXO1—muscle cancer	0.000593	0.00163	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Doxorubicin—muscle cancer	0.000592	0.00235	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—muscle cancer	0.000589	0.00234	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—muscle cancer	0.000577	0.00229	CcSEcCtD
Hydroxocobalamin—MMAB—Disease—KIT—muscle cancer	0.000572	0.00157	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—KIT—muscle cancer	0.000572	0.00157	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000566	0.00155	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MED12—muscle cancer	0.000559	0.00153	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Methotrexate—muscle cancer	0.000557	0.00221	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—muscle cancer	0.000554	0.0022	CcSEcCtD
Hydroxocobalamin—MTR—Disease—HMGA1—muscle cancer	0.000553	0.00152	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—FOXO1—muscle cancer	0.000548	0.0015	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Doxorubicin—muscle cancer	0.000541	0.00214	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—MDM2—muscle cancer	0.00054	0.00148	CbGpPWpGaD
Hydroxocobalamin—Dyspepsia—Doxorubicin—muscle cancer	0.000534	0.00212	CcSEcCtD
Hydroxocobalamin—TCN2—Disease—KIT—muscle cancer	0.000532	0.00146	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000524	0.00208	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—muscle cancer	0.000519	0.00206	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—TP53—muscle cancer	0.000516	0.00142	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Methotrexate—muscle cancer	0.000516	0.00205	CcSEcCtD
Hydroxocobalamin—CASP9—Innate Immune System—FOXO1—muscle cancer	0.000513	0.00141	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ENO2—muscle cancer	0.00051	0.0014	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TP53—muscle cancer	0.000506	0.00139	CbGpPWpGaD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—muscle cancer	0.0005	0.00198	CcSEcCtD
Hydroxocobalamin—MTR—Disease—FOXO4—muscle cancer	0.000496	0.00136	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Methotrexate—muscle cancer	0.000496	0.00197	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—FOXO1—muscle cancer	0.000493	0.00135	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—MDM2—muscle cancer	0.000492	0.00135	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Doxorubicin—muscle cancer	0.000482	0.00191	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—muscle cancer	0.00048	0.0019	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—muscle cancer	0.000479	0.0019	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—PTGS2—muscle cancer	0.000475	0.0013	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TP53—muscle cancer	0.000474	0.0013	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KIT—muscle cancer	0.000474	0.0013	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KIT—muscle cancer	0.000474	0.0013	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Methotrexate—muscle cancer	0.000463	0.00184	CcSEcCtD
Hydroxocobalamin—CASP9—Disease—ENO2—muscle cancer	0.000458	0.00126	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KIT—muscle cancer	0.000452	0.00124	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—MDM2—muscle cancer	0.00045	0.00124	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—MDM2—muscle cancer	0.00045	0.00124	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—FOXO1—muscle cancer	0.00045	0.00123	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—muscle cancer	0.000447	0.00177	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—muscle cancer	0.000442	0.00175	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—muscle cancer	0.000441	0.00175	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—muscle cancer	0.000439	0.00174	CcSEcCtD
Hydroxocobalamin—TCN1—Disease—PTGS2—muscle cancer	0.000434	0.00119	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PTGS2—muscle cancer	0.000434	0.00119	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Doxorubicin—muscle cancer	0.000429	0.0017	CcSEcCtD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000428	0.00117	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—MDM2—muscle cancer	0.000419	0.00115	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KIT—muscle cancer	0.000417	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HMGA1—muscle cancer	0.000417	0.00114	CbGpPWpGaD
Hydroxocobalamin—Nausea—Methotrexate—muscle cancer	0.000416	0.00165	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—muscle cancer	0.000415	0.00165	CcSEcCtD
Hydroxocobalamin—CASP9—Immune System—FOXO4—muscle cancer	0.000405	0.00111	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PTGS2—muscle cancer	0.000404	0.00111	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Doxorubicin—muscle cancer	0.000401	0.00159	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—PTGS2—muscle cancer	0.000398	0.00109	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KIT—muscle cancer	0.000391	0.00107	CbGpPWpGaD
Hydroxocobalamin—Rash—Doxorubicin—muscle cancer	0.000383	0.00152	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—muscle cancer	0.000382	0.00152	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—muscle cancer	0.00038	0.00151	CcSEcCtD
Hydroxocobalamin—CASP9—Adaptive Immune System—KIT—muscle cancer	0.000375	0.00103	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FOXO4—muscle cancer	0.000374	0.00103	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—MDM2—muscle cancer	0.000373	0.00102	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—MDM2—muscle cancer	0.000373	0.00102	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FOXO1—muscle cancer	0.000367	0.00101	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PTGS2—muscle cancer	0.000364	0.000998	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PTGS2—muscle cancer	0.000364	0.000998	CbGpPWpGaD
Hydroxocobalamin—Nausea—Doxorubicin—muscle cancer	0.00036	0.00143	CcSEcCtD
Hydroxocobalamin—AMN—Disease—PTGS2—muscle cancer	0.00036	0.000987	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PTGS2—muscle cancer	0.00036	0.000987	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MDM2—muscle cancer	0.000356	0.000977	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PTGS2—muscle cancer	0.000343	0.000942	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KIT—muscle cancer	0.000343	0.00094	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—muscle cancer	0.000338	0.000928	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MDM2—muscle cancer	0.000329	0.000902	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—muscle cancer	0.000317	0.000869	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—MDM2—muscle cancer	0.000308	0.000845	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTCH1—muscle cancer	0.000304	0.000835	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—muscle cancer	0.000301	0.000827	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—muscle cancer	0.000301	0.000827	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FOXO1—muscle cancer	0.000299	0.00082	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—MDM2—muscle cancer	0.000296	0.000811	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—muscle cancer	0.000287	0.000789	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KIT—muscle cancer	0.000279	0.000766	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FOXO1—muscle cancer	0.000276	0.000757	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MDM2—muscle cancer	0.00027	0.00074	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—muscle cancer	0.000265	0.000728	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FOXO4—muscle cancer	0.000262	0.000718	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—muscle cancer	0.00026	0.000714	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CNR1—muscle cancer	0.000257	0.000705	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KIT—muscle cancer	0.000228	0.000625	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—muscle cancer	0.00022	0.000604	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—muscle cancer	0.000218	0.000598	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—muscle cancer	0.000212	0.000582	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KIT—muscle cancer	0.00021	0.000577	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF2—muscle cancer	0.00021	0.000576	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FOXO1—muscle cancer	0.000193	0.00053	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—muscle cancer	0.000179	0.000492	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—muscle cancer	0.000178	0.000487	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—muscle cancer	0.000166	0.000454	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—muscle cancer	0.00016	0.000438	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KIT—muscle cancer	0.000147	0.000404	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—muscle cancer	0.000116	0.000318	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—muscle cancer	8.81e-05	0.000242	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—muscle cancer	6.65e-05	0.000183	CbGpPWpGaD
